Claret Asset Management Corp Has $116,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Claret Asset Management Corp cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 8.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,381 shares of the pharmacy operator’s stock after selling 1,110 shares during the period. Claret Asset Management Corp’s holdings in Walgreens Boots Alliance were worth $116,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Virtu Financial LLC acquired a new stake in shares of Walgreens Boots Alliance during the third quarter worth $208,000. Westside Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 14.3% in the third quarter. Westside Investment Management Inc. now owns 11,587 shares of the pharmacy operator’s stock worth $104,000 after purchasing an additional 1,454 shares in the last quarter. Wealthquest Corp acquired a new position in Walgreens Boots Alliance in the third quarter valued at approximately $130,000. Sanctuary Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 79.0% in the 3rd quarter. Sanctuary Advisors LLC now owns 46,333 shares of the pharmacy operator’s stock valued at $401,000 after acquiring an additional 20,450 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in Walgreens Boots Alliance during the third quarter worth $92,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Up 0.8 %

Shares of WBA stock opened at $10.89 on Friday. The firm has a market cap of $9.42 billion, a P/E ratio of -1.06, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The business has a 50-day moving average price of $10.85 and a two-hundred day moving average price of $10.13.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same quarter in the prior year, the company earned $1.20 earnings per share. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

WBA has been the subject of a number of research analyst reports. Evercore ISI boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their target price for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $10.59.

View Our Latest Stock Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.